Medication Management

Author

Oak Lawn Pharmacy

Posted on

Jul 13, 2022

Book/Edition

Texas - Dallas, Collin, SE Denton & Rockwall Counties

Share This

What is Medication Management?

Medication management is the process of ensuring the medications prescribed for a patient are taken properly and achieving their planned, therapeutic outcome.

A critical aspect of successful medication management is medication adherence which means taking the right dose, at the right time, in the right way and frequency.

Many patients do not follow health-care provider instructions on how to take medications for various reasons. Such as, not understanding the directions, forgetfulness, multiple medications with different regimens, unpleasant side effects or the medication doesn’t seem to be working.

Importance of Medication Management?

  • 20 to 30 percent of new prescriptions are never filled at the pharmacy.
  • Medication is not taken as prescribed 50 percent of the time.
  • For patients prescribed medications for chronic diseases, after six months, the majority take less medication than prescribed or stop the medication altogether.
  • Only 51 percent of patients taking medications for high blood pressure continue taking their medication during their long-term treatment.

The results of this are poor health outcomes, increased doctor visits, potential overdoses, and increased readmissions to the hospital, particularly for people with chronic conditions.

Prolonged illness can weaken immune systems and physical strength, causing additional illness or falls. And poor outcomes can land patients back in the hospital or on a revolving door of doctor visits.

Your pharmacist is an expert in medications, find one that you trust to work with you and your doctor on how best to take your medications.

Tips For Managing Medications:

  • If medication side effects are bothering you, talk with your doctor or pharmacist immediately to find a solution.
  • Make sure you understand how long to take the medication.
  • Tell your doctor or pharmacist if medication cost is an issue.
  • For example, our pharmacist can help shop coupons for you to manage costs.
  • Set daily routines to take medication.
  • Keep medications where you’ll notice them.
  • Use daily dosing containers or RX Med Packs.
  • Keep a written or computerized schedule for reminders.

Active Ways To Stay On Top Of Your Medications

  • Ask your doctor for a current medication list at the end of each visit.
  • Bring a detailed list of your medications, including name, dosage, and regimen to each doctor's appointment.
  • Taking photos of the prescription labels using a smartphone may be useful.
  • Ask your doctor or pharmacy about the benefits of pharmacy “pill packs" or other medication management services.
  • Visit with your doctor or pharmacist about known drug interactions with supplements or other the counter medications.
  • Seek recommendations and information on an automated, pill reminder app.

Keep Your Medications Safe

  • Keep your medications out of direct sunlight and heat.
  • Keep your medicine away from pets and children.
  • Don't store your medications with other family member medicines or household cleaners.
  • Keep medicines in their original bottles.
  • Dispose of expired medications/medications you no longer use
  • Ensure you communicate all medications you are taking with your doctors.

Article submitted by Oaklawn Pharmacy. To learn more about Med Packs call 214-954-7389 or visit www.oaklawnpharmacy.com

Other Articles You May Like

Aducanumab and Lecanemab: How are they different?

Aducanumab and Lecanemab: How are they different?Aducanumab and Lecanemab are both medications for the treatment of Alzheimer's disease. Aducanumab is a monoclonal antibody that targets beta-amyloid, a protein that accumulates in the brain and is associated with the development of Alzheimer's. Lecanemab is also a monoclonal antibody but it targets a different structure of beta-amyloid, called N3pG, which is believed to play a key role in the formation of amyloid plaques in the brain.The main difference between Aducanumab and Lecanemab is their mechanism of action. Aducanumab works by removing beta-amyloid from the brain, while Lecanemab works by blocking the formation of amyloid plaques in the brain.In clinical trials, Lecanemab has been shown to remove amyloid more quickly than Aducanumab or another medication called gantenerumab. Lecanemab has also shown a lower incidence of a side effect called ARIA (amyloid-related imaging abnormalities) compared to Aducanumab in clinical trials.It is important to note that both medications are still under investigation and more research is needed to fully understand their benefits and limitations. The choice of medication will ultimately depend on a patient's specific needs and circumstances, and should be made in consultation with a healthcare provider.Additionally, Aducanumab is approved for use in some countries, including the U.S., but is still awaiting approval in others. Lecanemab as of January 6th, 2023, has been approved by the U.S. Food and Drug Administration (FDA) through the Accelerated Approval pathway.Both Aducanumab and Lecanemab are part of a growing body of research into new treatments for Alzheimer's disease, which remains one of the most challenging and devastating neurological conditions. There are currently limited treatment options for Alzheimer's, and the development of new and effective therapies is a major priority for researchers and clinicians.While both medications show promise in their ability to target beta-amyloid, it is important to remember that treating Alzheimer's is a complex process that involves addressing multiple factors, including genetics, lifestyle, and environment.In conclusion, the differences between Aducanumab and Lecanemab lie in their mechanism of action and stage of development. Further research is needed to determine the long-term safety and efficacy of these medications in the treatment of Alzheimer's disease. As with any medical treatment, it is important to consult with a healthcare provider to determine the best course of action for an individual patient.Author:  Kathleen Warshawsky, RN, BSN | Publisher Seniors Blue BookOther articles you may like:Aducanumab and Lecanemab: How are they different?The Success of Lecanumab (Leqembi) in Treating Alzheimer's DiseaseThe Success of Aducanumab in Treating Alzheimer's Disease

The Success of Lecanumab (Leqembi) in Treating Alzheimer's Disease

The Success of Lecanumab (Leqembi) in Treating Alzheimer's DiseaseAlzheimer's disease is a debilitating and progressive brain disorder that affects more than 6.5 million Americans. It slowly erodes memory and thinking skills, and eventually the ability to carry out simple tasks. Despite the efforts of researchers and scientists, the specific causes of Alzheimer's disease are still not fully known. However, the disease is characterized by changes in the brain such as amyloid beta plaques and neurofibrillary tangles that result in the loss of neurons and their connections. These changes impact a person's ability to remember and think, leading to a decline in cognitive function.Leqembi, also known as lecanemab-irmb, is a new treatment for Alzheimer's disease that as of January 6th, 2023, has been approved by the U.S. Food and Drug Administration (FDA) through the Accelerated Approval pathway. This new treatment represents an important advancement in the ongoing battle against Alzheimer's disease, as it targets the fundamental pathophysiology of the disease, rather than merely treating its symptoms.Leqembi's efficacy was evaluated in a double-blind, placebo-controlled, parallel-group, dose-finding study of 856 patients with Alzheimer's disease. The study showed that patients receiving the approved dose of Leqembi (10 milligrams/kilogram every two weeks) had a statistically significant reduction in brain amyloid plaque compared to the placebo arm. The amyloid beta plaque was quantified using positron emission tomography (PET) imaging, and was estimated in a composite of brain regions that are expected to be widely affected by Alzheimer's disease pathology.The results of this study support the accelerated approval of Leqembi, which is based on the observed reduction of amyloid beta plaque, a marker of Alzheimer's disease. The prescribing information for Leqembi includes a warning for amyloid-related imaging abnormalities (ARIA) and a risk of infusion-related reactions. However, the most common side effects of Leqembi were infusion-related reactions, headache, and ARIA.The FDA granted Leqembi Fast Track, Priority Review, and Breakthrough Therapy designations, highlighting the significance of this new treatment for Alzheimer's disease. Leqembi's approval marks a major milestone in the fight against Alzheimer's disease, providing hope for patients and their families who have been affected by this devastating condition.Leqembi has been proven to be an effective treatment for Alzheimer's disease, offering a new hope for patients and their families. The results of the clinical trial demonstrate a significant reduction in brain amyloid plaque, a hallmark of Alzheimer's disease, and provide a strong foundation for further research and development in this field.References:      U.S. Food and Drug Administration. (2023, January 6). FDA Grants Accelerated Approval for Alzheimers Disease Treatment. [Press Release]. Retrieved from https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-disease-treatment      Leqembi. (n.d.). Medication Guide. Retrieved from https://www.leqembi.com/-/media/Files/Leqembi/Medication-Guide.pdf?hash=d4e8f584-6cf3-41c4-a7f3-34bda6abb800Author: Kathleen Warshawsky, BSN, RN | Publisher Seniors Blue BookOther articles you may like:Aducanumab and Lecanemab: How are they different?The Success of Lecanumab (Leqembi) in Treating Alzheimer's DiseaseThe Success of Aducanumab in Treating Alzheimer's Disease

The Success of Aducanumab in Treating Alzheimer's Disease

The Success of Aducanumab in Treating Alzheimer's DiseaseAducanumab is a medication that has received a lot of attention in recent years for its potential in treating Alzheimer's disease. Alzheimer's is a progressive neurological disorder that affects memory, thinking, and behavior, and there is currently no cure for the condition. Aducanumab is a type of drug called a monoclonal antibody, which works by targeting and removing sticky deposits of a protein called beta-amyloid that build up in the brains of individuals with Alzheimer's.Aducanumab has shown promising results in treating Alzheimer's disease. It is a monoclonal antibody that targets beta-amyloid, a protein that accumulates in the brain and is associated with the development of Alzheimer's. The drug works by removing beta-amyloid from the brain, slowing the progression of the disease and potentially improving cognitive function.In clinical trials, Aducanumab has been shown to reduce beta-amyloid levels in the brain and slow cognitive decline in patients with early Alzheimer's disease. The results of these trials have been highly promising and have led to the approval of Aducanumab by regulatory agencies in several countries.One of the most significant findings of the clinical trials was the observation of a statistically significant reduction in clinical decline in patients who received Aducanumab. This reduction in decline was observed in measures of cognitive function, such as memory and thinking skills, as well as in measures of daily functioning, such as the ability to perform basic activities of daily living.Another important finding from the trials was the observation of a favorable safety profile for Aducanumab. The majority of patients who received the medication did not experience significant side effects, and those that did were generally mild and manageable.In November 2021, the United States Food and Drug Administration (FDA) granted accelerated approval for Aducanumab as a treatment for Alzheimer's disease. This decision was based on evidence from clinical trials, as well as on the need for new treatments for Alzheimer's, which is a growing global health crisis. The FDA has required the manufacturer of Aducanumab, Biogen, to conduct additional studies to confirm the drug's benefits and to better understand its risks and side effects.The development of Aducanumab has been the subject of numerous clinical trials, with positive results seen in early trials in reducing beta-amyloid deposits in the brains of individuals with Alzheimer's. It is important to note however, that more recent trials have produced mixed results, with some studies showing a slowing of cognitive decline in individuals taking Aducanumab and others showing little to no effect.Aducanumab is a promising new treatment option for Alzheimer's, although more research is needed to determine its long-term safety and effectiveness. Individuals and their families should discuss with their healthcare provider the potential benefits and risks of taking Aducanumab, as well as other treatment options that may be available.In conclusion, Aducanumab is a medication that has received attention for its potential in treating Alzheimer's disease. The drug works by targeting and removing beta-amyloid deposits in the brain, which is believed to contribute to the progression of the disease. While the results of clinical trials have been mixed, the FDA has granted accelerated approval for Aducanumab as a treatment for Alzheimer's, with additional studies required to confirm its benefits and risks. Individuals and their families should consult with their healthcare provider to determine if Aducanumab is the right treatment option for them.References:      Alzheimer's Association. (2021). Aducanumab.      Biogen. (2021). Aducanumab.      FDA. (2021). Aducanumab Approval Letter.      National Institute on Aging. (2021). Alzheimer's Disease and Dementia. Author: Kathleen Warshawsky, BSN, RN | Publisher Seniors Blue Book Greater Dallas Other articles you may like:Aducanumab and Lecanemab: How are they different?The Success of Lecanumab (Leqembi) in Treating Alzheimer's DiseaseThe Success of Aducanumab in Treating Alzheimer's Disease

Local Services By This Author

Oak Lawn Pharmacy

Pharmacies 4003 Lemmon Ave, Dallas, Texas, 75219

Never Worry About Managing Your Medications Again. We put our years of experience as a trusted local North Texas pharmacy to work developing a system that makes it easy for you to keep track of what medication to take and when to take it with our labeled daily medication packs. Every month, our team will include a detailed list of your medications and dosage instructions with your shipment. We'll also include images so youll never wonder which pill is which. Throughout our packaging process, our pharmacists will inspect every Rx Med Pack at multiple checkpoints to ensure accuracy.Leave the Details to UsCoordinating With DoctorsOnce we have your doctors information and insurance, well coordinate all the details while you rest and relax.Transferring PrescriptionsDont worry about setting up your service or transferring your prescriptions. You send us your information and well take care of the rest.Packaging Your Pills We sort your pills by date and time and separate them into individual, easy-to-open packets.Scheduling Your ShipmentNo more chasing down refills because we will handle that for you! Our full-service pharmacy in North Texas will arrange your first shipment then automatically order your refills before you need them. Plus, enjoy free delivery right to your door.Safe and Thorough Packaging With Detailed InstructionsNever Worry About Managing Your Medications AgainWe put our years of experience as a trusted local North Texas pharmacy to work developing a system that makes it easy for you to keep track of what medication to take and when to take it with our labeled daily medication packs.Every month, our team will include a detailed list of your medications and dosage instructions with your shipment. Well also include images so youll never wonder which pill is which. Throughout our packaging process, our pharmacists will inspect every Rx Med Pack at multiple checkpoints to ensure accuracy. With DoctorsOnce we have your doctors information and insurance, well coordinate all the details while you rest and relax.Transferring PrescriptionsDont worry about setting up your service or transferring your prescriptions. You send us your information and well take care of the rest.Packaging Your Pills We sort your pills by date and time and separate them into individual, easy-to-open packets.Scheduling Your ShipmentNo more chasing down refills because we will handle that for you! Our full-service pharmacy in North Texas will arrange your first shipment then automatically order your refills before you need them. Plus, enjoy free delivery right to your door.